Gabriella Miller Kids First Research Act 2.0

To require certain civil penalties to be transferred to a fund through which amounts are made available for the Gabriella Miller Kids First Pediatric Research Program at the National Institutes of Health, and for other purposes. 1. Short title This Act may be cited as the Gabriella Miller Kids First Research Act 2.0 2. Transfer of funds to the Pediatric Research Initiative Section 30A of the Securities Exchange Act of 1934 ( 15 U.S.C. 78dd–1 (h) Transfer of amounts (1) In general Except as provided under section 21F, the Secretary of the Treasury shall transfer to the Pediatric Research Initiative Fund described in section 9008(i)(2) Fund (A) registered under subsection (b)(1) or (i)(1)(A)(i) of section 510 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360 (B) registered under subsection (b)(2) or (i)(1)(A)(ii) of section 510 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360 (C) that produce, manufacture, sell, transport, or distribute dietary supplements (as defined in section 201(ff) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(ff) (D) that produce, manufacture, sell, transport, or distribute cosmetics (as defined in section 201(i) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(i) (2) Exception for funds to be paid to harmed investors Paragraph (1) shall not apply to any monetary sanction collected by the Commission in any judicial or administrative action brought by the Commission under the securities laws that is added to a disgorgement fund or other fund under section 308 of the Sarbanes-Oxley Act of 2002 ( 15 U.S.C. 7246 (3) Application Amounts transferred to the Fund under this subsection shall be— (A) transferred in the manner described in section 9601 (B) available as described in section 9008(i)(2) of such Code. . 3. Funding for the Pediatric Research Initiative (a) In general Section 402A(a)(2) of the Public Health Service Act ( 42 U.S.C. 282a(a)(2) (1) in the paragraph heading, by striking 10-year (2) by striking the Common Fund the Division of Program Coordination, Planning, and Strategic Initiatives (3) by striking 10-Year (4) by inserting before the period the following: , and amounts transferred into the Pediatric Research Initiative Fund under subsection (h) of section 30A of the Securities Exchange Act of 1934 ( 15 U.S.C. 78dd–1 (b) NIH Director Section 402(b)(7)(B)(ii) of the Public Health Service Act ( 42 U.S.C. 282(b)(7)(B)(ii) the Common Fund the Division of Program Coordination, Planning, and Strategic Initiatives (c) Use of amounts for initiative Section 9008(i)(2) 10-year 4. Coordination of NIH funding for pediatric research (a) Sense of Congress It is the sense of Congress that the Director of the National Institutes of Health should oversee and coordinate research that is conducted or supported by the National Institutes of Health for research on pediatric cancer and other pediatric diseases and conditions, including through the Pediatric Research Initiative Fund. (b) Avoiding duplication Section 402(b)(7)(B)(ii) of the Public Health Service Act ( 42 U.S.C. 282(b)(7)(B)(ii) and shall prioritize such pediatric research that does not duplicate existing research activities of the National Institutes of Health ; and

Summary: Gabriella Miller Kids First Research Act 2.0 This bill modifies funding for a pediatric disease research initiative within the National Institutes of Health (NIH). Currently, this initiative receives funding through FY2023 from the 10-Year Pediatric Research Initiative Fund. This bill directs certain penalties assessed by the Securities and Exchange Commission against pharmaceutical companies for specified violations to that fund. In making allocations from the fund, the NIH must prioritize pediatric research that does not duplicate existing research activities.